|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 401/12 | (2006.01) |
| A61K 31/4439 | (2006.01) | ||
| A61P 25/06 | (2006.01) |
| (11) | Number of the document | 3334721 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16751123.7 |
| Date of filing the European patent application | 2016-08-05 | |
| (97) | Date of publication of the European application | 2018-06-20 |
| (45) | Date of publication and mention of the grant of the patent | 2021-04-28 |
| (46) | Date of publication of the claims translation | 2021-07-26 |
| (86) | Number | PCT/US2016/045698 |
| Date | 2016-08-05 |
| (87) | Number | WO 2017/027345 |
| Date | 2017-02-16 |
| (30) | Number | Date | Country code |
| 201562203996 P | 2015-08-12 | US | |
| 201562266867 P | 2015-12-14 | US |
| (72) |
COATES, David Andrew, US
FORTNER, Kevin Charles, US
MASSEY, Steven Marc, US
MYERS, Jason Kenneth, US
NAVARRO, Antonio, US
SIEGEL, Miles Goodman, US
STUCKY, Russell Dean, US
|
| (73) |
Eli Lilly and Company,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | CGRP receptoriaus antagonistai |
| CGRP RECEPTOR ANTAGONISTS |
| Payment date | Validity (years) | Amount | |
| 2022-07-20 | 7 | 162.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-08-05 |